Healthcare


 Why Celyad Oncology (CYAD) stocks rally on Friday?

Why Celyad Oncology (CYAD) stocks rally on Friday?

December 04, 2021 07:36 AM AEDT| By Versha Jain

Highlights The stocks of Celyad Oncology (CYAD) were up over 45% on Friday morning. Fortress Investment invested US$32.5 million in Celyad through a private placement. Fortress purchased 6.5 million shares of Celyad’s common stocks. .....

 Longeveron Inc (LGVN) stock’s record rally continues - Know why?

Longeveron Inc (LGVN) stock’s record rally continues - Know why?

December 04, 2021 06:24 AM AEDT| By Versha Jain

Highlights Longeveron Inc. (NASDAQ: LGVN) stock rallied on Friday as its common stock offering in a private placement draws to a close. Longeveron Inc. had launched its IPO in February 2021. The LGVN stock gained 218% since the launch. It rose.....

 Cumberland (CPIX) stock jumped 100% today – Here’s why

Cumberland (CPIX) stock jumped 100% today – Here’s why

December 01, 2021 07:07 AM AEDT| By Versha Jain

Highlights Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) stock soared more than 100% on Tuesday. The biotechnology company grew by 55% YTD. FDA has approved expanded labeling of its pain reliever injection for pre-operative administratio.....

 HCA Healthcare, Inc. (HCA) stock price, YTD gain – among top performers

HCA Healthcare, Inc. (HCA) stock price, YTD gain – among top performers

December 01, 2021 06:47 AM AEDT| By Sanjeeb Baruah

Highlights The HCA Healthcare, Inc. stock gained nearly 40% this year. The stock’s 52-week highest and the lowest stock prices were US$263.92 and US$148.92, respectively. The Nashville, Tennessee-based company on Tuesday announced plans t.....

 First Wave BioPharma (FWBI) stock soars over 36% on upbeat trial data

First Wave BioPharma (FWBI) stock soars over 36% on upbeat trial data

December 01, 2021 04:11 AM AEDT| By Versha Jain

The First Wave BioPharma, Inc. (NASDAQ: FWBI) stock rose more than 36% in the premarket on Tuesday after announcing the data monitoring committee’s (DMA) decision to continue enrollment of its Reservoir Phase 2 trials for covid-related g.....

 Five hot healthcare stocks to watch as Omicron threat looms

Five hot healthcare stocks to watch as Omicron threat looms

November 30, 2021 08:58 AM AEDT| By Versha Jain

Highlights The Florida-based NRX Pharmaceuticals, Inc. develops novel therapeutics for central nervous system disorders and life-threatening pulmonary diseases. The Pennsylvania-based Krystal Biotech, Inc. develops treatments for skin diseases......

 Why is Allied Healthcare (AHPI) stock up 53% Friday?

Why is Allied Healthcare (AHPI) stock up 53% Friday?

November 27, 2021 08:17 AM AEDT| By Rupam Roy

Highlights Stocks of Allied Healthcare Products rallied over 53% in the premarket on Friday. WHO is likely to convene to discuss the spread of a new Covid variant in South Africa. The AHPI stock price surged over 4% YTD. Stocks of Allied .....

 Guess why Moderna (MRNA) stock jumped 23% Friday?

Guess why Moderna (MRNA) stock jumped 23% Friday?

November 27, 2021 06:56 AM AEDT| By Rupam Roy

Highlights Moderna’s covid vaccine was found to be most effective among four other drugs in a study. Its vaccine had an effectiveness of 88.8% against covid infection and 93.6% against covid-related deaths. The MRNA stock price grew over.....

 Biofrontera stock (BFRI) rallies 115%, fired up by upbeat rating

Biofrontera stock (BFRI) rallies 115%, fired up by upbeat rating

November 25, 2021 05:50 AM AEDT| By Rupam Roy

Highlights Analysts raised the 12-month stock price target to US$20. The BFRI jumped 115% in intraday trading after the positive comments. The Massachusetts-based company specializes in dermatology drugs and medical cosmetics, mainly for skin .....

 Ocuphire Pharma (OCUP) stock jumped 34% - know why?

Ocuphire Pharma (OCUP) stock jumped 34% - know why?

November 25, 2021 03:39 AM AEDT| By Rupam Roy

Highlights Ocuphire Pharma announced the number of participants for the MIRA-3 Phase 3 trial. CEO Mina Sooch said the company will submit a new drug application (NDA) for Nyxol eye drops after the trial results. The company reported a net loss.....

 Pasithea Therapeutics (KTTA) stock soars 229% - Know why?

Pasithea Therapeutics (KTTA) stock soars 229% - Know why?

November 24, 2021 07:29 AM AEDT| By Rupam Roy

Highlights Pasithea Therapeutics' (KTTA) wholly-owned subsidiary Pasithea Clinics got approval for its anti-depressant esketamine nasal spray, SPRAVATO. The KTTA stock jumped over 229% in intraday trading on Tuesday. Currently, only three clin.....

 Qualigen (QLGN) stock jumped 32% Tuesday – Is it worth the price?

Qualigen (QLGN) stock jumped 32% Tuesday – Is it worth the price?

November 24, 2021 06:27 AM AEDT| By Versha Jain

Highlights Qualigen Therapeutics, Inc. (NASDAQ: QLGN) soared 32% in intraday trading on Tuesday. Its third-quarter revenue rose to US$US$1.16 million compared to a net loss of US$8.11 million a year ago. The company develops novel therapeutic .....

 Aadi Bioscience (AADI) stock soars on FDA approval for FYARRO

Aadi Bioscience (AADI) stock soars on FDA approval for FYARRO

November 24, 2021 03:07 AM AEDT| By Rupam Roy

Highlights Aadi Bioscience announced FDA approval for its injectable drug FYARRO. FYARRO is the only FDA-approved therapy for advanced malignant PEComa in adults. The AADI stock rose over 62% YTD. Shares of Aadi Bioscience, Inc. (NASDAQ: .....

 Why is iSpecimen Inc. (ISPC) stock making headlines today?

Why is iSpecimen Inc. (ISPC) stock making headlines today?

November 23, 2021 05:26 AM AEDT| By Rupam Roy

Highlights iSpecimen Inc. (ISPC) said that it secured a contract to support new research on covid. The stocks were up more than 130% on Monday morning. The company's revenue was up 21% YoY in Q3, FY21. The stocks of the online marketplace.....

 Why ObsEva SA (OBSV) stock jumped on Monday?

Why ObsEva SA (OBSV) stock jumped on Monday?

November 23, 2021 04:08 AM AEDT| By Rupam Roy

Highlights FDA has agreed to review the new drug application (NDA) for Linzagolix. It has set Sep 13, 2022, as a target date for the NDA review under the Prescription Drug User Fee Act (PDUFA). ObsEva announced the appointment of Stephanie Bro.....

 Longeveron (LGVN) shares soared 138%, do you know why?

Longeveron (LGVN) shares soared 138%, do you know why?

November 19, 2021 05:00 AM AEDT| By Rupam Roy

Highlights FDA has granted rare-pediatric-disease (RPD) designation to Longeveron’s cellular therapy Lomecel-B. Longeveron is currently evaluating Lomecel-B in a Phase 2 trial. All the infants enrolled in its Lomecel-B Phase 1 trial were.....

 Pfizer funding in Cardiff Oncology drives CRDF 21% higher. Know more

Pfizer funding in Cardiff Oncology drives CRDF 21% higher. Know more

November 19, 2021 04:55 AM AEDT| By Versha Jain

Highlights Cardiff Oncology, Inc. (NASDAQ: CRDF) stock jumped 21% in premarket Thursday. The company has received a US$15 million equity investment from Pfizer Inc. Cardiff plans to use the proceeds for its ongoing clinical research in KRAS-mu.....

 Dicerna-Novo Nordisk deal revealed: DRNA stock pops 78% in premarket

Dicerna-Novo Nordisk deal revealed: DRNA stock pops 78% in premarket

November 19, 2021 03:18 AM AEDT| By Versha Jain

Highlights Novo Nordisk will acquire Dicerna Pharmaceuticals for US$3.3 billion. After the acquisition, Novo expects to begin the clinical development of its first investigational therapeutic in 2022. The transaction, which would be de.....

 Progenity (PROG) stock continues rally, up 21%: Here’s why

Progenity (PROG) stock continues rally, up 21%: Here’s why

November 18, 2021 03:32 AM AEDT| By Raza Naqvi

Highlights Progenity, Inc. (NASDAQ: PROG) will participate in Piper Sandler 33rd Annual Virtual Healthcare Conference The company's revenue surged over 220% in Q3, FY21 PROG stocks were up more than 20% in pre-market trading today The sto.....

 Why did Altamira Therapeutics (CYTO) stock skyrocket today?

Why did Altamira Therapeutics (CYTO) stock skyrocket today?

November 13, 2021 07:29 AM AEDT| By Ipsita Sarkar

Highlights Altamira Therapeutics Ltd. (NASDAQ: CYTO) announces positive test results for Bentrio nasal spray. The company received FDA approval for Bentrio on Oct 14. Altamira’s operating loss was about US$7.01 million for the six months.....

Recent Articles






Investing Tips

Previous Next